dna
vaccin
induc
humor
cellular
immun
respons
anim
model
human
analyz
immunogen
sever
acut
respiratori
syndrom
sar
coronaviru
cov
sarscov
spike
dna
vaccin
immunoregulatori
activ
dna
vaccin
plasmid
pcdna
construct
inocul
balbc
mice
without
use
three
differ
immun
rout
intramuscular
rout
electropor
oral
rout
live
attenu
salmonella
enterica
serovar
typhimurium
cellular
humor
immun
respons
assess
enzymelink
immunosorb
assay
lymphocyt
prolifer
assay
enzymelink
immunospot
assay
fluorescenceactiv
cell
sorter
analys
result
show
specif
humor
cellular
immun
could
induc
mice
inocul
sarscov
spike
dna
vaccin
alon
coinocul
plasmid
addit
immun
respons
level
coinocul
group
significantli
higher
group
receiv
spike
dna
vaccin
alon
find
show
spike
dna
vaccin
good
immunogen
induc
specif
humor
cellular
immun
balbc
mice
play
immunoadjuv
role
enhanc
humor
cellular
immun
respons
differ
vaccin
rout
also
evok
distinct
immun
respons
studi
provid
basic
inform
design
dna
vaccin
sarscov
intern
outbreak
sever
acut
respiratori
syndrom
sar
atyp
form
pneumonia
caus
case
death
across
countri
start
emerg
midnovemb
august
etiolog
sar
identifi
new
coronaviru
cov
name
sarscov
sarscov
genom
approxim
bp
encod
four
main
structur
protein
includ
spike
protein
membran
protein
envelop
e
protein
nucleocapsid
n
protein
glycoprotein
respons
bind
receptor
host
cell
play
import
role
membran
fusion
moreov
antibodi
protein
neutral
viru
vitro
also
protect
lethal
sarscov
challeng
previous
shown
pseudotyp
lentivir
particl
bear
sarscov
protein
could
inhibit
sera
sar
patient
addit
tcell
epitop
identifi
sarscov
protein
shown
elicit
tcell
respons
sarscovinfect
patient
henc
protein
attract
target
therapeut
vaccin
develop
sever
sarscov
sproteinbas
vaccin
shown
gener
antibodi
cellular
immun
respons
therefor
studi
focus
sarscov
protein
target
antigen
develop
dna
vaccin
dna
vaccin
induc
cellular
humor
immun
respons
produc
longlast
immun
infecti
diseas
howev
low
immunogen
dnabas
vaccin
could
compromis
applic
vaccin
recent
year
mani
effort
made
enhanc
immun
respons
elicit
dna
vaccin
includ
coexpress
cytokin
use
heterolog
primeboost
regimen
use
convent
rout
deliveri
dna
vaccin
plasmid
cytokin
adjuv
use
augment
dna
vaccineelicit
humor
cellular
immun
respons
anim
model
potent
cytokin
activ
multipl
compart
immun
system
sever
studi
report
immun
respons
dna
vaccin
dramat
enhanc
coadministr
plasmid
encod
gene
exampl
phenomenon
report
dna
vaccin
bovin
herp
viru
type
hepat
c
viru
hepat
b
viru
bovin
viral
diarrhea
viru
human
immunodefici
viru
footandmouth
diseas
viru
measl
viru
gene
use
cytokin
adjuv
sarscov
dna
vaccin
therefor
immunemodul
effect
sarscov
sprotein
dna
vaccin
investig
current
studi
addit
dna
adjuv
vaccin
rout
anoth
import
factor
influenc
effici
immun
number
method
develop
increas
effici
plasmid
deliveri
apart
convent
intramuscular
im
rout
immun
recent
experi
demonstr
electropor
greatli
enhanc
vaccin
plasmid
associ
increas
level
gene
express
addit
electropor
display
adjuv
qualiti
increas
gene
express
anoth
conveni
dna
vaccin
deliveri
system
oral
vaccin
live
attenu
salmonella
enterica
serovar
typhimurium
use
attenu
strain
salmonella
vehicl
deliveri
plasmid
dna
vivo
effect
method
induct
strong
cellmedi
humor
immun
respons
mucos
site
thu
particularli
interest
immun
electropor
immun
oral
rout
live
attenu
salmonella
enterica
serovar
typhimurium
vivo
studi
directli
compar
immun
respons
gener
use
differ
rout
vaccin
sarscov
dna
immun
therefor
studi
immunogen
vaccin
sarscov
sprotein
dna
without
vector
deliv
im
rout
electropor
oral
rout
live
attenu
enterica
serovar
typhimurium
compar
mous
model
plasmid
bacteri
strain
invitrogen
carlsbad
ca
use
vector
dna
vaccin
fulllength
sprotein
gene
sarscov
amplifi
pfastbacdul
construct
state
key
laboratori
virolog
wuhan
institut
virolog
mous
gene
kindli
provid
cui
boan
henan
agricultur
univers
zhengzhou
peopl
republ
china
sprotein
gene
subclon
construct
recombin
plasmid
pcdna
respect
accuraci
construct
confirm
restrict
digest
sequenc
dna
plasmid
purifi
megaprep
column
qiagen
dissolv
endotoxinfre
phosphatebuff
salin
pb
final
concentr
gl
store
attenu
enterica
serovar
typhimurium
strain
atcc
phopc
kindli
provid
guo
aizhen
huazhong
agricultur
univers
school
anim
medicin
wuhan
peopl
republ
china
use
carrier
oral
genet
immun
anim
immun
sixto
femal
balbc
mice
purchas
center
experiment
anim
hubei
medic
colleg
randomli
divid
group
eight
anim
per
group
anim
provid
pathogenfre
water
food
mice
immun
three
time
interv
im
rout
electropor
oral
rout
enterica
serovar
typhimurium
immun
schedul
summar
tabl
immun
dose
g
plasmid
per
anim
inject
quadricep
muscl
immun
electropor
anim
anesthet
inject
g
plasmid
pcdna
im
rear
thigh
twoneedlearray
electrod
insert
muscl
immedi
inject
dna
electropor
array
insert
longitudin
rel
direct
muscl
fiber
vivo
electropor
perform
model
squarewav
gener
btx
san
diego
ca
paramet
follow
distanc
electrod
puls
length
six
puls
revers
polar
three
puls
oral
immun
attenu
enterica
serovar
typhimurium
strain
cell
harbor
pcdna
dna
vaccin
cultur
grown
reach
optic
densiti
nm
od
cell
harvest
centrifug
resuspend
highest
requir
densiti
pb
sigma
inoculum
enterica
serovar
typhimurium
dilut
appropri
concentr
ml
sodium
bicarbon
buffer
mous
immun
oral
gavag
cfu
enterica
serovar
typhimurium
transform
pcdna
group
contain
immun
follow
g
per
mous
im
rout
g
electropor
cfu
oral
immun
dna
dosag
number
cfu
attenu
enterica
serovar
typhimurium
strain
use
treat
mice
optim
seri
preliminari
experi
analysi
humor
immun
respons
antisarscov
antibodi
level
serum
assess
enzymelink
immunosorb
assay
elisa
chemic
kill
sarscov
purifi
use
detect
antigen
optim
concentr
gml
antigen
coat
onto
plate
costar
overnight
plate
wash
block
bovin
serum
albumin
buffer
solut
h
prior
incub
mous
serum
dilut
bound
antibodi
detect
alkalin
phosphataseconjug
goat
antimous
immunoglobulin
g
igg
sigma
color
develop
ad
paranitrophenylphosph
substrat
read
plate
reader
biorad
valu
obtain
sera
mice
experiment
group
consid
posit
time
valu
control
group
valu
includ
similar
elisa
protocol
follow
assess
sproteinspecif
igg
subclass
case
recombin
protein
express
escherichia
coli
purifi
use
detect
antigen
horseradish
peroxidaseconjug
goat
antimous
igg
sigma
use
secondari
antibodi
od
read
lpa
antigenspecif
lymphocyt
prolifer
assay
lpa
perform
describ
previous
brief
day
follow
final
inject
mice
kill
singlecel
suspens
prepar
spleen
group
splenocyt
per
well
rpmi
medium
sigma
supplement
fetal
bovin
serum
seed
plate
triplic
cultur
stimul
follow
variou
condit
h
co
gml
concanavalin
cona
posit
control
gml
purifi
sprotein
antigen
specif
antigen
gml
bovin
serum
albumin
irrelev
antigen
medium
alon
neg
control
celltit
aqueou
one
solut
reagent
l
promega
ad
well
accord
manufactur
protocol
follow
incub
read
prolif
activ
estim
use
stimul
index
si
calcul
mean
od
antigencontain
well
divid
mean
od
well
without
antigen
sarscov
sproteinspecif
elispot
cellular
immun
respons
sarscov
assess
gamma
interferon
enzymelink
immunospot
assay
elispot
mous
splenocyt
assay
perform
accord
instruct
manual
ucytech
netherland
ninetysixwel
plate
coat
gml
rat
antimous
lwell
pb
overnight
plate
wash
three
time
pb
contain
tween
block
pb
contain
fetal
bovin
serum
h
three
addit
wash
pb
contain
tween
splenocyt
l
reaction
buffer
contain
gml
purifi
protein
ad
well
plate
incub
h
march
guest
http
cviasmorg
co
wash
time
pb
biotinyl
antimous
monoclon
antibodi
dilut
subsequ
ad
plate
incub
h
room
temperatur
plate
wash
streptavidinbiotinyl
horseradish
peroxidas
ad
plate
incub
addit
hour
room
temperatur
follow
five
wash
pb
individu
plate
contain
develop
obtain
dark
spot
reaction
peroxidas
substrat
reaction
stop
rins
plate
deminer
water
plate
air
dri
room
temperatur
absorb
read
use
elispot
reader
hitech
instrument
number
spotform
cell
per
splenocyt
calcul
medium
background
consist
spotform
cell
per
splenocyt
determin
cell
peripher
blood
mononuclear
cell
flow
cytometri
use
monitor
express
tcell
surfac
marker
direct
immunofluoresc
perform
standard
techniqu
describ
elsewher
cell
assess
day
final
boost
vaccin
lymphocyt
isol
peripher
blood
mononuclear
cell
stain
follow
monoclon
antibodi
fluorescein
isothiocyanatelabel
antimous
antibodi
antimous
antibodi
phycoerythrinlabel
antimous
antibodi
bd
pharmingen
correspond
isotyp
control
one
hundr
thousand
cell
acquir
facscalibur
flow
cytomet
data
analyz
winmdi
softwar
becton
dickinson
lincoln
park
nj
statist
analysi
data
present
mean
immun
mice
group
standard
deviat
sd
spss
softwar
window
use
statist
analysi
differ
humor
cellular
immun
respons
group
assess
use
singlefactor
analysi
varianc
leastsignificantdiffer
test
use
betweengroup
comparison
p
valu
consid
statist
signific
present
studi
plasmid
pcdna
pcdna
plu
use
immun
mice
im
rout
electropor
oral
rout
attenu
enterica
serovar
typhimurium
examin
humor
respons
elicit
vaccin
level
antisarscov
antibodi
immun
mice
determin
elisa
sera
collect
day
final
boost
vaccin
assay
result
shown
fig
group
immun
induc
significantli
higher
level
antisarscov
igg
compar
control
group
immun
pb
p
immun
pcdna
electropor
induc
highest
level
antibodi
among
achiev
three
rout
vaccin
immun
oral
rout
evok
lowest
level
antibodi
among
achiev
three
rout
vaccin
antibodi
level
group
pcdna
coadminist
significantli
higher
group
receiv
pcdna
alon
p
group
immun
pcdna
plu
antibodi
respons
induc
im
inject
compar
induc
immun
oral
rout
p
significantli
lower
induc
immun
electropor
p
sproteinspecif
antibodi
antibodi
subclass
ten
day
final
immun
level
sproteinspecif
antibodi
mous
sera
determin
elisa
fig
vaccin
mice
develop
substanti
antibodi
respons
wherea
anim
control
group
show
detect
sproteinspecif
antibodi
respons
tendenc
mice
immun
group
achiev
sproteinspecif
igg
antibodi
respons
consist
mice
achiev
antisarscov
antibodi
respons
fig
level
measur
determin
humor
immun
respons
profil
shown
fig
antisarscov
igg
subtyp
profil
reveal
induc
immun
regimen
antibodi
level
group
vaccin
combin
vaccin
show
greater
increas
group
vaccin
pcdna
although
antibodi
subclass
profil
similar
group
antibodi
produc
anim
vaccin
im
mainli
subclass
level
subclass
induc
group
vaccin
mucos
oral
rout
appreci
higher
level
subclass
induc
interest
group
immun
electropor
predomin
mice
immun
pcdna
alon
major
subclass
anim
vaccin
plu
pcdna
case
coadministr
pcdna
mainli
enhanc
antibodi
respons
chang
antibodi
subclass
type
sproteinspecif
tcell
prolifer
activ
prolifer
lymphocyt
play
critic
role
march
guest
http
cviasmorg
humor
cellular
immun
respons
induc
vaccin
therefor
next
evalu
whether
vaccin
pcdna
presenc
absenc
immun
differ
rout
could
influenc
antigenspecif
tcell
prolifer
shown
fig
higher
level
lymphocyt
stimul
protein
observ
mice
immun
pcdna
alon
pcdna
plu
control
p
level
cell
prolifer
anim
coimmun
appreci
higher
anim
immun
pcdna
alon
p
level
splenocyt
prolifer
respons
oral
immun
pcdna
pcdna
plu
consist
significantli
higher
respons
immun
two
rout
p
immun
im
rout
induc
stronger
tcell
respons
immun
electropor
result
indic
immun
pcdna
pcdna
plu
elicit
recogniz
level
antigenspecif
tcell
respons
immun
oral
rout
evok
strongest
immun
respons
sproteinspecif
respons
elispot
use
assess
magnitud
sproteinspecif
tcell
respons
mice
vaccin
pcdna
dna
pcdna
plu
protein
dosag
use
stimul
number
splenocyt
optim
induc
tcell
respons
data
shown
splenocyt
vaccin
mice
harvest
day
final
vaccin
sproteinspecif
level
enumer
elispot
shown
fig
b
small
number
nonspecif
cell
detect
control
group
elispot
cell
elispot
background
count
well
contain
splenocyt
absenc
mitogen
nomin
antigen
control
group
signific
number
sproteinspecif
spot
detect
immun
group
elispot
p
compar
immun
pcdna
alon
twoor
threefold
increas
antigenspecif
cell
number
detect
mice
coimmun
pcdna
three
immun
rout
p
howev
cell
number
high
cell
number
group
pcdna
coadminist
appreci
higher
group
immun
pcdna
alon
immun
mice
oral
rout
induc
lowest
igg
level
appreci
isotyp
elicit
significantli
higher
level
immun
im
rout
p
electropor
p
moreov
group
induc
much
higher
level
result
suggest
vaccin
formul
immunogen
like
induc
stronger
bia
lymphocyt
respons
sinc
activ
lymphocyt
among
crucial
compon
antivir
effector
respons
lymphocyt
assess
vaccin
mice
fig
flow
cytometr
analysi
unstimul
cell
use
standard
background
respons
littl
variat
respons
among
nonimmun
mice
vaccin
pcdna
pcdna
plu
significantli
increas
percentag
activ
cell
fig
sproteinspecif
lpa
pool
splenocyt
obtain
mice
three
mice
per
group
immun
dna
vaccin
day
postimmun
splenocyt
stimul
vitro
protein
test
group
cona
posit
control
bovin
serum
albumin
irrelev
antigen
control
splenocyt
control
group
immun
pb
stimul
protein
serv
neg
control
sham
control
si
calcul
use
follow
formula
mean
od
conaor
antigenstimul
prolifer
mean
od
nonstimul
prolifer
bar
repres
mean
si
sd
three
mice
number
activ
cell
increas
immun
group
ratio
group
immun
pcdna
plu
higher
group
immun
pcdna
three
immun
rout
differ
statist
signific
p
moreov
immun
oral
rout
induc
substanti
respons
immun
electropor
induc
neglig
respons
result
parallel
ig
respons
group
immun
electropor
induc
highest
level
lowest
level
result
reinforc
fact
sprotein
dna
vaccin
elicit
tcell
respons
mice
use
three
immun
rout
express
enhanc
tlymphocyt
activ
induc
sprotein
dna
vaccin
present
studi
new
dna
vaccin
approach
investig
coadminist
plasmid
pcdna
plasmid
encod
murin
cdna
use
three
immun
rout
clearli
show
vaccin
sarscov
sprotein
dna
elicit
sarscov
sproteinspecif
humor
cellular
immun
respons
respons
significantli
enhanc
coadministr
vector
anim
trial
also
show
administr
dna
vaccin
candid
differ
immun
rout
could
induc
qualit
differ
immun
respons
profil
find
provid
basic
inform
design
dna
vaccin
target
antigen
protein
sarscov
result
antisarscov
antisproteinspecif
antibodi
tcell
prolifer
activ
cell
shown
success
evok
sprotein
dna
vaccin
also
found
antigenspecif
cell
capabl
secret
high
level
cytokin
moder
level
cytokin
upon
vitro
stimul
sarscov
protein
result
indic
sprotein
dna
vaccin
activ
subset
level
activ
subset
much
higher
correl
tendenc
antibodi
level
elev
find
suggest
sprotein
dna
vaccin
effect
activ
b
cell
gener
antisprotein
antibodi
cellular
immun
mainli
respons
mice
result
consist
observ
sarscov
dna
vaccin
studi
sever
studi
indic
codeliveri
vector
encod
cytokin
granulocytemacrophag
colonystimul
factor
abl
direct
natur
result
immun
respons
augment
efficaci
dna
vaccin
cytokin
potent
activ
multipl
compart
immun
system
includ
thelper
cell
cytotox
cell
b
cell
macrophag
nk
cell
evid
suggest
coadministr
plasmid
encod
given
antigen
result
enhanc
humor
cellmedi
immun
respons
antigen
mostli
favor
cell
differenti
current
studi
immun
respons
mice
immun
sarscov
sprotein
dna
vaccin
alon
compar
mice
coimmun
plasmid
encod
analyz
antibodi
tcell
prolifer
thelpercel
respons
tcell
respons
mice
receiv
adjuv
rapidli
gener
igg
antibodi
data
shown
antibodi
level
much
higher
mice
given
antigenencod
plasmid
alon
antibodi
level
increas
group
immun
combin
domin
isotyp
chang
coinject
vector
similar
pattern
observ
tcell
immun
respons
measur
lpa
elispot
fluorescenceactiv
cell
sorter
analysi
result
show
immun
pcdna
plu
elicit
recogniz
higher
level
tcell
respons
compar
group
immun
pcdna
alon
taken
togeth
result
provid
evid
strategi
includ
adjuv
use
enhanc
protect
immun
candid
sarscov
vaccin
result
consist
previou
find
obtain
anim
model
chronic
viral
infect
show
administr
enhanc
viral
antigenspecif
immun
respons
improv
clinic
outcom
document
rout
method
immun
import
modul
vaccin
dna
vaccin
dna
vaccin
deliv
im
rout
needl
intraderm
rout
subcutan
rout
gene
gun
electropor
oral
rout
live
attenu
bacteria
gener
immun
inject
induc
humor
cellular
immun
respons
recent
found
applic
electr
field
tissu
vivo
significantli
increas
level
dna
uptak
gene
express
howev
oral
immun
use
salmonella
vaccin
bear
foreign
antigen
induc
strong
protect
immun
spons
wide
varieti
infecti
diseas
anim
model
oral
vaccin
influenc
immun
profil
augment
mucos
cellular
immun
compar
achiev
administr
inject
sarscov
vaccin
previous
describ
immun
salmonellacarri
sprotein
peptid
induc
protect
antibodi
therefor
investig
whether
differ
vaccin
rout
could
chang
immun
type
especi
gene
adjuv
combin
sarscov
dna
vaccin
facilit
dna
vaccin
deliveri
mous
model
chose
three
differ
immun
rout
im
rout
electropor
oral
rout
use
live
attenu
enterica
serovar
typhimurium
vaccin
without
describ
administ
immun
rout
evalu
comparison
studi
effici
immun
schedul
result
show
immun
im
rout
induc
moder
tcell
respons
antibodi
respons
predominantli
compris
respons
respons
better
obtain
oral
immun
vaccin
electropor
result
highest
antibodi
respons
among
three
rout
immun
midlevel
cellular
respons
contrast
dna
vaccin
deliv
oral
live
attenu
salmonella
vigor
tcell
respons
weak
antibodi
product
domin
subclass
evok
subclass
antibodi
respons
evok
immun
three
rout
suggest
process
antigen
recogn
cell
associ
addit
three
vaccin
rout
enhanc
immun
respons
observ
group
coimmun
dna
includ
increas
antigenspecif
prolif
respons
higher
level
product
increas
tcell
number
result
suggest
distinct
type
immun
respons
gener
due
differ
immun
rout
coimmun
dna
basi
observ
vaccin
dna
oral
rout
induc
strong
tcellmedi
immun
respons
wherea
immun
im
rout
electropor
induc
moder
tcell
respons
vigor
antibodi
respons
studi
carri
use
combin
oral
inject
immun
stimul
higher
cellular
humor
immun
respons
addit
result
also
show
deliveri
dna
vaccin
electropor
oral
use
live
attenu
salmonella
vivo
effect
method
increas
level
antigen
express
muscl
tissu
lead
mark
improv
immun
respons
note
deliveri
dna
differ
rout
induc
differ
immun
respons
profil
might
due
differ
way
present
sprotein
antigen
profession
antigenpres
cell
deliv
im
rout
electropor
oral
rout
live
attenu
enterica
serovar
typhimurium
could
select
infect
cell
dna
encod
protein
select
carri
mucosaassoci
lymphoid
tissu
cell
term
cell
peptid
within
cell
might
cleav
present
major
histocompat
complex
mhc
class
pathway
give
rise
strong
cellular
respons
hand
small
amount
sprotein
peptid
gener
cell
might
secret
present
b
cell
mhc
class
ii
pathway
result
poor
antibodi
respons
studi
mhc
class
class
ii
pathway
simultan
evok
extent
im
electropor
immun
rout
support
find
studi
hepat
b
viru
dna
vaccin
present
live
attenu
enterica
serovar
typhimurium
similar
result
also
report
zheng
et
al
show
live
oral
vaccin
mice
enterica
serovar
typhimurium
deliv
dnahbsag
oral
dna
vaccin
evok
vigor
tcell
respons
weak
antibodi
respons
predominantli
subclass
thu
differ
formul
plasmid
dna
vaccin
induc
distinct
immun
respons
apart
differ
way
antigen
present
antigenpres
cell
reason
differ
rout
vaccin
administr
evok
distinct
immun
respons
sarscov
protein
may
differ
amount
dna
use
differ
rout
although
dose
dna
requir
stimul
immun
optim
differ
immun
rout
refin
immun
condit
especi
dna
immun
dose
requir
ensur
maxim
expans
sarscov
sprotein
dna
vaccin
effector
dna
immun
well
model
mice
assess
optim
paramet
immun
type
immun
respons
produc
dna
vaccin
also
hold
promis
use
human
howev
effect
mice
may
dramat
human
current
technolog
signific
limit
prevent
full
effect
dna
vaccin
larger
anim
mani
aspect
still
remain
consid
prior
develop
dna
vaccin
sarscov
human
present
report
demonstr
sarscov
sprotein
dna
vaccin
coadminist
plasmid
induc
specif
immun
respons
mice
howev
run
test
anim
model
still
unknown
whether
approach
could
appli
anim
model
immunogen
human
remain
establish
therefor
import
evalu
efficaci
sarscov
dna
vaccin
highli
relev
translat
model
demonstr
respons
human
studi
conduct
valid
whether
type
vaccin
extend
human
